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        Introduction 
  BubR1 protein kinase is an essential component of the mitotic 
checkpoint in metazoans (  Cahill et al., 1998  ;   Taylor et al., 1998  ), 
where one of its roles is to act as a mechanosensor that monitors 
the microtubule attachment status of kinetochores through its 
interaction with the kinesin-like motor centromere protein (CENP) 
E (  Schaar et al., 1997  ;   Chan et al., 1999  ;   Yao et al., 2000  ;   McEwen 
et al., 2001  ;   Mao et al., 2003  ,   2005  ). In addition to its check-
point roles at the kinetochore, BubR1 is part of the mitotic check-
point complex (MCC) that acts downstream of the kinetochore 
by directly inhibiting the anaphase-promoting complex/cyclo-
some (APC/C;   Sudakin et al., 2001  ;   Braunstein et al., 2007  ; 
  Musaro et al., 2008  ). Separate from its checkpoint functions, 
BubR1 has been shown to be essential for proper kinetochore 
microtubule attachments ( Lampson and Kapoor, 2005 ). Recently, 
BubR1 was reported to associate with adenomatous polyposis 
coli, and its kinase activity regulated the ability of the adenoma-
tous polyposis coli  –  EB1 complex to establish kinetochore/
microtubule attachments (  Kaplan et al., 2001  ;   Zhang et al., 2007  ). 
  BubR1 is hyperphosphorylated in mitosis (  Chan et al., 
1999  ;   Taylor et al., 2001  ), but its signifi  cance to kinetochore 
attachments and checkpoint regulation was not known. Recent 
studies have shown that human BubR1 can be phosphorylated 
by Plk1, and these modifi  cations are critical for stable kineto-
chore attachments (  Elowe et al., 2007  ;   Matsumura et al., 2007  ). 
Similarly,   Xenopus    laevis   BubR1 is a substrate of Plx1, and the 
phosphorylation generates the 3F3/2 phosphoepitope that is im-
portant for the checkpoint in egg extracts ( Wong and Fang, 2007 ). 
We report the identifi  cation of four new mitosis-specifi  c phos-
phorylation sites that are not targets of Plk1 or aurora B kinases. 
Their functional importance was examined with phosphospe-
cifi  c antibodies and various phosphomutants. We demonstrate 
that the phosphorylation of S670 and S1043 at kinetochores is 
sensitive to loss of microtubule attachments but not to tension. 
This contrasts with the response of the Plk1 S676 phosphoryla-
tion that is sensitive to tension (  Elowe et al., 2007  ). Cells ex-
pressing phosphodefective (S to A) and phosphomimic (S to D) 
BubR1 mutants were delayed in metaphase because of defective 
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for checkpoint inhibition of the anaphase-promoting com-
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nases that are involved in discrete aspects of kinetochore 
attachments and checkpoint regulation.
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lacked pS670 and pS1043 staining even though BubR1 was still 
detectable. Thus, S670 and S1043 are phosphorylated at kineto-
chores upon mitotic entry and are dephosphorylated at the onset 
of anaphase (  Fig. 1 A   and Fig. S2 C). 
  Examination of the phosphorylation status of BubR1 in 
lysates that were harvested at various times after cells were re-
leased from a nocodazole block showed that S543, S670, and 
S1043 were gradually dephosphorylated as cells exited mitosis 
when compared with S435, which was completely dephosphor-
ylated by the time cyclin B1 was degraded (Fig. S2 E). We noted 
that the kinetics of S670 and S1043 dephosphorylation, as de-
termined by blots, differed from the abrupt loss of phospho-
signal as determined by staining. This difference was attributed 
to the fact that the cytosolic pool of BubR1 was extracted 
from cells before fi  xing and staining. When extraction was 
omitted, pS670 signal was detected in the cytosol of early/
midanaphase cells (Fig. S2 F). As chromosomes were absent 
from lysates used for blots, the phosphosignals likely refl  ect 
the cytosolic pool of BubR1. 
  We next tested whether the variable intensity of pS670 stain-
ing at kinetochores of prometaphase and early metaphase cells 
was caused simply by changes in the amount of BubR1 or 
refl  ected differences in the phosphorylation state of BubR1. 
We determined the relative BubR1 levels among individual kineto-
chores within a cell by normalizing the signals to the kineto-
chore with the highest intensity (100%) as described previously 
(  Hoffman et al., 2001  ;   Feng et al., 2006  ;   Liu et al., 2006  ;   H. Huang 
et al., 2007  ). The relative pS670 intensities among the identi-
cal set of kinetochores were determined by normalizing to the 
strongest phospho-BubR1 signal (this comparison was indepen-
dent of the BubR1 normalization). By comparing the ratio of 
the normalized intensities of pS670 with BubR1, it was possible 
to determine whether the differences in BubR1 phosphorylation 
were caused simply by changes in total BubR1 levels or actual 
changes in its phosphorylation state (  Fig. 1 C  ). A ratio of 1 indi-
cates that the phosphorylation was directly related to the amount 
of BubR1 at the kinetochore. Ratios   <  1 would indicate that 
BubR1 was dephosphorylated at kinetochores, as shown in late 
metaphase and early anaphase. Kinetochores in prometaphase tend 
to exhibit stronger BubR1 phosphorylation (ratio   >  1). The dis-
tribution pattern for early metaphase kinetochores was broader, and 
there was a clear shift toward the dephosphorylated state. Thus, 
the changes in BubR1 phosphorylation in prometaphase and meta-
phase probably refl  ect differences in kinetochore attachments. 
  We next compared the pS670/BubR1 ratios in cells that 
were treated with nocodazole and taxol to suppress microtubule 
dynamics. This produced unattached kinetochores that are Mad1 
positive as well as bipolar-attached kinetochores that lack de-
tectable Mad1 staining but fail to generate full tension (  Fig. 1 B  ). 
pS670/BubR1 ratios were increased at unattached kinetochores, 
as was seen at many of the kinetochores in normal prometa-
phase (  Fig. 1 C  ) and when microtubules were completely de-
polymerized after treatment with a high dose of nocodazole. BubR1 
phosphorylation was reduced at many of the attached but ten-
sionless kinetochores. Thus, S670 is phosphorylated and de-
phosphorylated at kinetochores in response to the absence and 
presence of microtubule attachments, respectively (  Fig. 1 C  ). 
kinetochore attachments that failed to generate proper levels of 
tension. Furthermore, analysis of these phosphomutants suggests 
that phosphorylation of S670 is critical for error correction at 
kinetochores. Injection of phospho-BubR1 antibodies also de-
layed cells at metaphase because kinetochores failed to generate 
proper levels of tension. 
  Using a cell-free system that recapitulated the checkpoint 
events that lie downstream of the kinetochore (  Sudakin et al., 
2001  ;   Braunstein et al., 2007  ), we found that the addition of 
phospho-S670 (pS670) antibodies prolonged the inhibition of the 
APC/C. Thus, the phosphorylation status of BubR1 may be a 
critical determinant of checkpoint activity. Finally, we show that 
Mps1 is a major upstream kinase of all four phosphorylation sites 
in vivo. Combining our data with others suggests that multiple 
kinases regulate BubR1 to facilitate proper kinetochore attach-
ments and checkpoint signaling. 
  Results 
  BubR1 is differentially phosphorylated at 
attached and unattached kinetochores 
 BubR1 was immunopurifi  ed from extracts prepared from asynchro-
nous and nocodazole-blocked HeLa cells. Mass spectrometry 
(Fig. S1, A and B, available at http://www.jcb.org/cgi/content/
full/jcb.200805163/DC1) identifi  ed four major signals that cor-
responded to phosphoserines (S453, S543, S670, and S1043). 
A minor peak at S676 was also identifi  ed that was one of several 
sites (S676, T792, and T1008) that were recently reported to 
be phosphorylated by Plk1 (  Elowe et al., 2007  ;   Matsumura et al., 
2007  ). Of the new phosphoresidues, S670 was conserved from 
  Drosophila    melanogaster   to humans, whereas the others exhib-
ited variable degrees of conservation among different species 
(Fig. S1 C). Phosphoantibodies were raised against the four phos-
phorylation sites. Western blots of mitotic lysates treated and 
untreated with      protein phosphatase showed that all four anti-
bodies were phosphospecifi  c (Fig. S2 A). Phosphospecifi  city 
of the pS670 and pS1043 antibodies was further confi  rmed as 
the signals obtained with blots were eliminated with phospho-
peptide but not with the unphosphorylated peptide (Fig. S2 B). 
In all subsequent experiments, unphosphopeptides were used to 
ensure phosphospecifi  city. Only the pS670 and pS1043 anti-
bodies did not exhibit strong cross-reactivity with other phospho-
proteins in Western blots of whole cell lysates, which allowed 
their use in immunocytochemistry. 
 Immunofl  uorescence staining showed that both pS670 and 
pS1043 antibodies produced identical patterns (  Fig. 1 A   and 
Fig. S2 C). Staining was sensitive to phosphopeptide but not to 
the unphosphorylated peptide (Fig. S2 D). To assess the phos-
phorylation status of BubR1 at kinetochores during different 
stages of mitosis, cells were costained with antibodies to detect 
pS670 and S1043 (rabbit) and total BubR1 (rat;   Fig. 1 A   and 
Fig. S2 C). BubR1 was detected at kinetochores as early as pro-
phase, but pS670 and pS1043 staining at kinetochores did not 
appear until after nuclear envelope breakdown (NEB) when cells 
entered mitosis. Phosphostaining remained detectable at kineto-
chores from prometaphase to metaphase. Some cells that were 
presumably more advanced in metaphase and in early anaphase 669 PHOSPHO  -  B  UB  R1 REGULATION OF KINETOCHORE FUNCTIONS   • Huang et al. 
  Figure 1.       BubR1 is differentially phosphorylated at attached and unattached kinetochores.   (A) HeLa cells were stained for pS670, BubR1, and DAPI. The 
arrows indicate kinetochores. Background signal is caused by incomplete extraction of the cytosol. (B) HeLa cells were blocked in mitosis with a low dose of 
nocodazole (20 ng/ml) and stained for pS670, BubR1, Mad1, ACA, and DAPI. (C) Intensities of pS670 and BubR1 signals at individual kinetochores were 
quantitated, and the values were normalized to the kinetochore with the highest intensity (100%). The normalized values of pS670 and BubR1 for each 
kinetochore were used to obtain a ratio of pS670/total BubR1 for each kinetochore and plotted. An example of differential intensities of pS670 relative to 
BubR1 at metaphase is presented. Kinetochores a  –  c showed weaker signals relative to d and e for pS670, whereas the same kinetochores, a  ’    –  e  ’  , showed 
equal signal intensities for BubR1. The dashed line indicates the position of the ratio of 1. Pro, prophase; Prometa, prometaphase; Meta, metaphase; Ana, 
anaphase; misaligned and aligned, monopolar and bipolar attachments, respectively.     JCB • VOLUME 183 • NUMBER 4 • 2008  670
vestigated by characterizing a series of phosphodefective (S to A) 
and phosphomimic (S to D) BubR1 mutants at a single or at all 
four sites. The BubR1 mutants were tagged with either 3  ×  Flag or 
GST and cloned into vectors with an H2B-GFP expression cas-
sette. RNAi-resistant alleles of the wild-type and BubR1 mutants 
were generated to facilitate experiments that included RNAi 
knockdown of endogenous BubR1 (  Fig. 2 B   and Fig. S3 A, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200805163/DC1). 
We fi rst established that all of the mutants along with wild-type 
These changes do not appear to be sensitive to the lack of ten-
sion as reported for the pS676 residue (  Elowe et al., 2007  ). 
  In vivo characterization of 
BubR1 phosphomutants 
  As BubR1 contributes to attachment as well as checkpoint-
monitoring functions at the kinetochore, the changes in pS670 
might refl  ect either or both of these activities. The functional sig-
nifi  cance of the mitotic phosphorylation sites in BubR1 was in-
  Figure 2.       Phospho-BubR1 mutants localize to kinetochores in cells depleted of endogenous BubR1.   (A and B) HeLa cells depleted of endogenous BubR1 
by siRNA were transfected with a vector that coexpressed 3  ×  Flag BubR1 
RNAi   (RNAi-resistant alleles) and H2B-GFP and were stained for Flag, hSgo2, and 
DAPI (A), or the lysates were probed for CENP-F, BubR1, and Flag (B). Western blots show siRNA-depleted endogenous BubR1 but not the 3  ×  Flag-BubR1. 
UN, untransfected cell lysate; WT, wild type.     671 PHOSPHO  -  B  UB  R1 REGULATION OF KINETOCHORE FUNCTIONS   • Huang et al. 
wild-type BubR1 entered anaphase on average 50 min after 
NEB, but some took as long as 120 min (  Fig. 3 B  , left). The ma-
jority (80%) of the cells entered anaphase     20 min after reach-
ing metaphase. These times are similar to cells transfected with 
H2B-GFP alone (  Fig. 3 B  , middle). The majority of the cells 
expressing the QA mutant took     100 min from NEB to ana-
phase, but cells that were delayed for   >  250 min were also seen 
BubR1 were able to localize to kinetochores in mitotic cells 
(  Fig. 2 A   and Fig. S3, B and C). We used time-lapse video-
microscopy to track the fates of transfected cells that ex-
pressed H2B-GFP. 
  Initial experiments focused on testing the quadruple phos-
phodefective (QA) and phosphomimic (QD) mutants in the pres-
ence of endogenous BubR1 (  Fig. 3 A  ). Cells expressing the 
  Figure 3.       BubR1 phosphomutants delay the metaphase to anaphase transition.   (A) HeLa cells released from a G1/S block were injected with 3  ×  Flag 
constructs, and H2B-GFP-expressing cells were monitored by time-lapse microscopy (hours:minutes). Select frames from videos of cells injected with wild-
type (WT) BubR1 and the quadruple phosphomutants (QA and QD) are shown. The arrow points to lagging chromosomes. (B) The videos were analyzed 
frame by frame, and the behavior of chromosomes was used to determine the percentage of cells from NEB to anaphase onset (left), from metaphase to 
anaphase onset (middle), and the frequencies of lagging chromosomes (right). For wild type,   n   = 20; QA,   n   = 27; QD,   n   = 44; vector,   n   = 22. (C) HeLa 
cells depleted of endogenous BubR1 by siRNA were released from a G1/S block and were injected with 3  ×  Flag  –  wild-type BubR1, KD, S670A, and S670D 
phosphomutant and empty vector. The cells that expressed H2B-GFP were monitored by time lapse and were quantitated as in B. For wild type,   n   = 30; 
S670A,   n   = 24; S670D,   n   = 21; KD,   n   = 35. Vec, control vector. (B and C) Error bars indicate the highest and lowest values within a dataset.     JCB • VOLUME 183 • NUMBER 4 • 2008  672
  In contrast to the QA and S670A mutants, virtually all 
(  >  98%) of the attached kinetochores examined in the QD and 
S670D mutants had end-on attachments (  Fig. 4, A and C  ). Nev-
ertheless, the attachments were also defective, as they failed to 
generate tension (  Fig. 4 B  ). The failure of end-on attachments 
to generate tension is reminiscent of kinetochores depleted of 
CENP-E (  Fig. 4, B  –  D  ;   Yao et al., 2000  ;   McEwen et al., 2001  ) or 
when microtubule dynamics are dampened pharmacologically. 
The combined data suggest that phosphorylation of S670 is 
critically important for kinetochores to resolve aberrant attach-
ments. However, phosphorylation is also important for end-on 
attachments to generate tension. 
  Phospho-BubR1 antibodies delay anaphase 
onset in vivo and in vitro 
  The in vivo signifi  cance of the pS670 and pS1043 residues was 
independently investigated by injecting a panel of phospho- and 
nonphospho-BubR1 antibodies into cells. HeLa cells released 
from a double thymidine block were injected several hours 
before they were scheduled to enter mitosis. Cells were either 
fi  xed for staining or were monitored by time-lapse microscopy. 
We fi rst determined that the various BubR1 antibodies were 
concentrated at kinetochores in the injected cells that had en-
tered mitosis (Fig. S4 A, available at http://www.jcb.org/cgi/
content/full/jcb.200805163/DC1). As shown previously (  Chan 
et al., 1999  ;   Shannon et al., 2002  ), cells injected with plain 
BubR1 antibodies prematurely exited mitosis before chromosomes 
achieved metaphase alignment. In support of our (  Chan et al., 
1999  ) and others  ’   RNAi experiments (  Meraldi et al., 2004  ), the 
BubR1 antibody  –  injected cells exited mitosis     10 min earlier 
than cells injected with nonimmune IgG. In contrast, cells injected 
with either the pS670 or pS1043 antibodies exhibited a meta-
phase delay of between 30 and 100 min before entering ana-
phase (  Fig. 5, A and B  ). 
  We were able to rule out nonspecifi  c steric effects by the 
injected pS1043 antibodies as an explanation for the metaphase 
delay. We had fortuitously raised a nonphosphoantibody (T1042) 
that spanned the same epitope used to raise the pS1043 anti-
bodies. Despite the fact that the injected T1042 antibodies were 
concentrated at kinetochores (Fig. S4 A), they did not interfere 
with chromosome alignment or with mitotic progression (  Fig. 5, 
A and B  ). Given that the peptides used to raise antibodies be-
tween T1042 and pS1043 were virtually identical, the clear dif-
ference in their in vivo response strongly suggests that the 
effects of the pS1043 antibodies were phosphospecifi  c. 
  We attempted to detect spindle or kinetochore defects in 
the phospho-BubR1 antibody  –  injected cells to identify a cause 
for the metaphase delay. Antibody injections did not interfere 
with the formation of a bipolar spindle or the accumulation of 
Mad1 and CENP-E at kinetochores (Fig. S4 C). Furthermore, 
the injected antibodies did not interfere with normal kineto-
chore attachments as determined by their stability to cold treat-
ment and the end-on nature of the microtubule attachments 
(  Fig. 5 C  ). Consistent with the behavior of the phosphomutants, 
the interkinetochore distances in the cells injected with pS670 
antibody (1.0   ±   0.1   μ  m) were reduced relative to the control 
(2.0   ±   0.2   μ  m). 
(  Fig. 3 B  , left). The QA mutant took approximately the same 
amount of time as wild-type and QD cells to align their chromo-
somes even though the metaphase plates were qualitatively not 
as tight as cells expressing wild type or the QD mutant (  Fig. 3 A  ). 
Compared with wild type, QA-expressing cells were delayed at 
metaphase for 20  –  100 min (  Fig. 3 B  , middle). The metaphase de-
lay was likely caused by aberrant attachments, as   >  60% of the 
QA cells that entered anaphase exhibited lagging chromosomes 
as compared with     5% seen in wild-type BubR1-expressing 
cells (  Fig. 3 B  , right). The majority (70%) of the cells that ex-
pressed the QD mutant also exhibited a metaphase delay (  Fig. 3 B  , 
left and middle). However, the frequency of lagging chromo-
somes exhibited by the QD mutant was threefold lower than the 
QA mutant (  Fig. 3 B  , right). 
  We next characterized the single phosphodefective (S670A) 
and phosphomimic (S670D) mutants in cells whose endogenous 
BubR1 were depleted by siRNA. This residue was selected be-
cause it was conserved among all vertebrate species examined. 
Time-lapse experiments showed that depletion of BubR1 accel-
erated cells into anaphase as previously described (  Meraldi 
et al., 2004  ). Transfected wild-type BubR1 rescued the BubR1-
depleted cells, as the kinetics of mitotic progression was restored 
to that seen in cells transfected with vector alone (  Fig. 3 C  , left 
and middle). Cells expressing either the S670A or S670D mu-
tants were able to achieve metaphase alignment with normal 
kinetics but were delayed by 20 to   >  150 min from entering ana-
phase (  Fig. 3 C  , left and middle). Over 90% of the cells depleted 
of BubR1 exhibited lagging chromosomes upon entry into ana-
phase (  Fig. 3 C  , right). The S670A mutant consistently failed to 
reduce the frequency of lagging chromosomes to that obtained 
with wild type and the S670D mutant. This suggests that the 
failure to phosphorylate S670 generates aberrant attachments 
that are not resolved when cells enter anaphase (  Fig. 4  ). 
  We discovered that the kinase-dead (KD) BubR1 mutant 
(  Elowe et al., 2007  ;   Matsumura et al., 2007  ) exhibited a mixed 
phenotype when compared with the phospho-BubR1 mutants 
(  Fig. 3 C  , left and middle). As with wild-type BubR1, the KD 
mutant restored mitotic progression to the BubR1-depleted cells, 
but unlike the phospho-BubR1 mutants, they did not exhibit a 
pronounced delay. Nevertheless, the high frequency of lagging 
chromosomes in anaphase indicated the presence of defective 
attachments that were not resolved at the time of exit. The mixed 
phenotype may be best explained if the KD mutant affected both 
kinetochore attachments and mitotic checkpoint control. 
  We used cold treatment to directly assess the integrity of the 
kinetochore attachments in BubR1-depleted cells that expressed 
the various transfected BubR1 mutants (  Fig. 4  ). All of the attach-
ments (100%) examined in wild-type  –  transfected cells exhibited 
proper bipolar end-on microtubule attachments that were under 
full tension ( Fig. 4, A – C ). As predicted, 13% and 11% of all attach-
ments in the QA and the S670A mutants, respectively, exhibited 
defects that included lateral, monotelic, syntelic, and others ( Fig. 4, 
A and C  ). These defects were very similar to those seen in cells 
expressing the KD BubR1 mutant. Although lack of tension gener-
ated by these defective attachments is likely responsible for the 
transient metaphase delay, it is noteworthy that kinetochores that 
established end-on connections also failed to generate tension. 673 PHOSPHO  -  B  UB  R1 REGULATION OF KINETOCHORE FUNCTIONS   • Huang et al. 
  Figure 4.       Phosphorylation of S670 is required for error correction and kinetochore tension.   (A) Synchronized HeLa cells depleted of BubR1 by siRNA were 
injected with various GST/BubR1 constructs and treated with MG132 to prevent mitotic exit. Coverslips were chilled on ice for 10 min, extracted, ﬁ  xed, 
and stained for GST, ACA, tubulin, and DAPI. Tubulin and ACA signals were deconvolved to visualize microtubule attachments at individual bioriented 
kinetochores that are shown in the insets. (B) Interkinetochore distances were measured between pairs of ACA foci with end-on attachments (50   <     n     <   100). 
Black bars represent the mean. (C) Histogram depicting the relative frequency of end-on and aberrant attachments (  n     >   50) in cells expressing various 
BubR1 constructs. Error bars indicate the range for each dataset. (D) HeLa cells depleted of CENP-E were cold treated and stained for ACA and tubulin to 
depict end-on attachments and kinetochore tension. WT, wild type.     JCB • VOLUME 183 • NUMBER 4 • 2008  674
in vitro, as addition of the phospho-BubR1 antibodies into 
mitotic HeLa lysates interfered with the ability of      protein 
phosphatase to dephosphorylate endogenous BubR1 (  Fig. 6 A  ). 
  We tested whether the ability of the pS670 and pS1043 
antibodies to delay anaphase onset might be caused by the pres-
ervation of these phosphoresidues. This possibility was confi  rmed 
  Figure 5.       Phospho-BubR1 antibodies delay anaphase onset in vivo.   (A) Select frames from time-lapse videos of HeLa H2B-GFP that were injected with the 
indicated antibodies. (B) Videos were analyzed frame by frame to determine the percentage of cells from NEB to anaphase onset. For pS670,   n   = 20; 
pS1043,   n   = 20; T1042,   n   = 30; BubR1,   n   = 12; control IgG,   n   = 23. Error bars represent the highest and lowest values for each timepoint. (C) Cells 
injected with nonimmune and pS670 IgG were cold treated and stained for ACA and tubulin to visualize kinetochore attachments (insets).     675 PHOSPHO  -  B  UB  R1 REGULATION OF KINETOCHORE FUNCTIONS   • Huang et al. 
the endogenous substrates for APC/C (  Fig. 6 B  ). Addition of 
different amounts of pS670 antibodies to the extracts prolonged 
the repression of APC/C activity in a dose-dependent fashion 
(  Fig. 6 C  ). Furthermore, the effects of the phospho-BubR1 anti-
bodies were neutralized if the antibodies were preincubated briefl  y 
with a 1.7-fold excess of phosphopeptide. APC/C activation 
was not delayed when similar amounts of the T1042 BubR1 
antibody were added to the extract. Furthermore, the addition of 
plain BubR1 antibodies accelerated the onset of APC/C activity 
(  Fig. 6 C  ). Thus, the responses of the extracts to the pS670, T1042, 
and plain BubR1 antibodies were similar to the response of cells 
that were injected with the same set of antibodies. 
  The level of pS670 in the extracts was reduced by 30 min 
of incubation and continued to decline (  Fig. 6 D  ). At 90 min, the 
level of Cdc27 phosphorylation that is specifi  ed in large part by 
Cdk1 ( Rudner and Murray, 2000 ;  Kraft et al., 2003 ;  J.Y. Huang et al., 
2007  ) was reduced. Addition of pS670 antibodies delayed the 
dephosphorylation rate of Cdc27 relative to controls. Based on 
these in vitro studies, one explanation for how the injected phospho-
BubR1 antibodies delayed metaphase is that they preserved 
the phosphorylation of BubR1, and this prolonged its ability to 
inhibit the APC/C. Similarly, the phosphomimic BubR1 mutants 
These experiments do not exclude other possibilities in which 
the phosphoantibody blocks the interaction of p670 BubR1 with 
critical factors important for generating kinetochore tension. 
  The metaphase delay exhibited by the phospho-BubR1 
mutants can be ascribed to defective kinetochore attachments. 
However, the delay may also be caused by the fact that BubR1 
can act downstream of the kinetochore as an inhibitor of the 
APC/C. We and recently others (  Sudakin et al., 2001  ;   Braunstein 
et al., 2007  ) have shown that BubR1 is part of the MCC that 
binds to and potently inhibits the APC/C in mitotic HeLa cells. 
Using a cell-free system (extracts prepared from nocodazole-
arrested HeLa cells) that recapitulates the mitotic checkpoint 
events that lie downstream of the kinetochore (  Braunstein et al., 
2007  ), we tested whether addition of the phospho-BubR1 anti-
bodies altered the kinetics of checkpoint inhibition. As shown 
previously (  Braunstein et al., 2007  ), control extracts incubated 
at 30  °  C remained in a checkpoint-arrested state for a brief pe-
riod before inhibition of APC/C is relieved, as is evident by the 
degradation of endogenous cyclin B1 (or securin;   Fig. 6 B   and 
not depicted). As has been shown, the degradation was depen-
dent on the APC/C, as the addition of peptide containing the 
wild-type destruction box of cyclin B1 effectively competed with 
  Figure 6.       Phospho-BubR1 antibodies prolong the lag in the APC/C activation in cell extracts.   (A) Mitotic extracts were incubated with      protein phospha-
tase (PPase) in the presence of pS670 or nonimmune IgG for 0, 30, 60, and 120 min. Membranes were probed for BubR1 to see changes in the mobility 
of BubR1 (top) and pS670 status (bottom). (B) Mitotic extracts were incubated with and without the N terminus of cyclin B1 (CycB), and samples were taken 
at various times and probed for endogenous cyclin B1. WT-N, wild-type cyclin B1 N-terminus fragment. (C) Extracts were incubated in the presence of the 
indicated antibodies (Abs) for various times, and the level of endogenous cyclin B1 was determined. 1  ×   = 0.8   μ  M of antibody or phosphopeptide. (D) Cell 
extracts with and without pS670 antibody were probed to evaluate the phosphorylation status of BubR1 (pS670) and Cdc27 (based on mobility shifts).     JCB • VOLUME 183 • NUMBER 4 • 2008  676
sensitive to kinetochore tension. Interestingly, this is opposite 
of the increased phosphorylation of S676 that was recently re-
ported to result from the loss of tension (  Elowe et al., 2007  ). 
Given that the sites reported here are not targets of Plk1, the dif-
ference in the phosphorylation response to loss of tension sug-
gests that BubR1 is differentially phosphorylated depending on 
the status of microtubule attachment and tension. 
  Phosphorylation of S670 appears to be important for error 
correction, as kinetochores containing the S670A mutant accu-
mulated aberrant attachments at an     15-fold higher frequency 
than wild type. This conclusion is strengthened by the fact that 
the S670D phosphomimic mutant is able to prevent the accumu-
lation of defective attachments as effectively as wild-type BubR1. 
The inability to correct these defective attachments by the S670A 
mutant explains the high incidence of lagging chromosomes in 
anaphase. As the attachment defects of the S670A mutant were 
similar to the KD mutant, the phosphorylation of S670 may act 
through its kinase domain (  Kaplan et al., 2001  ;   Matsumura et al., 
2007  ;   Zhang et al., 2007  ). The defective attachments reported 
here are similar to those reported for the Plk1 phosphodefective 
mutants (  Elowe et al., 2007  ;   Matsumura et al., 2007  ). Thus, it is 
possible that phosphorylation of BubR1 at S670 affects its 
could have contributed to the metaphase delay by extending the 
actions of the cytosolic inhibitor of the APC/C in addition to their 
effects on kinetochore attachments. 
  Mps1 is required to phosphorylate BubR1 
in cells 
  Recent studies showed that BubR1 is phosphorylated by Plk1 
(  Elowe et al., 2007  ;   Matsumura et al., 2007  ) and aurora B 
( Ditchfi  eld et al., 2003  ;   Hauf et al., 2003  ). Western blots using 
the four phosphopeptide antibodies showed that none of them 
were affected in mitotic cells treated with the aurora kinase 
inhibitor hesperadin. Furthermore, treatment of cells with rosco-
vitine, a Cdk inhibitor, or staurosporine did not affect these 
phosphorylation sites (Fig. S5, A and B, available at http://www
.jcb.org/cgi/content/full/jcb.200805163/DC1). pS670 levels were 
unaffected in mitotic cells that were depleted of aurora B or Plk1 
by siRNA (Fig. S5, C  –  E). In cells that were depleted of   >  90% 
of their Mps1 kinase, phosphorylation of S435, S543, S670, and 
S1043 was reduced to     25% of control levels (  Fig. 7  ). Mps1 is 
a major but not the exclusive kinase that specifi  es BubR1 phos-
phorylation in vivo. 
  Discussion 
  BubR1 is hyperphosphorylated in mitosis, and some of the sites 
depend on aurora B and Plk1 kinases (  Ditchfi  eld et al., 2003  ; 
  Elowe et al., 2007  ;   King et al., 2007  ;   Lenart et al., 2007  ; 
  Matsumura et al., 2007  ). Although the sites that are dependent 
on aurora B remain to be identifi  ed, three candidate Plk1 sites 
were recently reported in human BubR1 (  Elowe et al., 2007  ; 
 Matsumura et al., 2007 ;  Wong and Fang, 2007 ). However, only one 
(S676) of the three sites was directly confi  rmed to exist in vivo. 
We have identifi  ed and confi  rmed with phosphoantibodies the 
existence of four additional mitosis-specifi  c  phosphorylation 
sites (S435, S543, S670, and S1043) that are not dependent on 
aurora B or Plk1 kinases. Instead, Mps1 appears to be a major, 
but not the only, kinase responsible for these phosphorylations 
in vivo. Whether it directly or indirectly phosphorylates BubR1 
will require in vitro experiments. The contribution of Cdk1 is 
unclear despite the fact that the addition of Cdk inhibitor to mi-
totic cells failed to inhibit phosphorylation of BubR1. It is possi-
ble that Cdk1 is important for phosphorylating BubR1 at the 
onset of mitosis and is not essential for maintaining the phos-
phorylated state. Finally, it is also possible that some of the phos-
phorylation sites may be caused by BubR1 autokinase activity. 
 Immunofl  uorescence staining with pS670 and pS1043 
antibodies showed that they fi  rst appeared at kinetochores at the 
onset of mitosis and were dephosphorylated at late metaphase 
and in early anaphase. Quantitative analysis showed that changes 
in the levels of pS670 at kinetochores were not caused solely by 
the fl  uctuations in BubR1 levels (  Hoffman et al., 2001  ). Thus, 
phosphorylation of S670 (and pS1043) indeed increased in re-
sponse to unoccupied microtubule-binding sites as seen during 
prometaphase. Upon microtubule attachment, S670 is de-
phosphorylated such that it is no longer detectable by late meta-
phase when kinetochores are fully saturated with microtubules. 
We found that dephosphorylation of pS670 was not directly 
  Figure 7.       Mps1 is required to phosphorylate BubR1 in cells.   Cells trans-
fected with control, and Mps1 siRNA were released from a double thymi-
dine block. MG132 was added 8 h later, and mitotic cells were harvested 
2 h later by shakeoff. Lysates were probed with all four phospho-BubR1 
antibodies. Two different amounts of control lysates were used, so it was 
possible to directly compare the band intensities with Mps1-depleted lysate. 
CENP-F, BubR1, and cyclin B1 were used as loading controls.     677 PHOSPHO  -  B  UB  R1 REGULATION OF KINETOCHORE FUNCTIONS   • Huang et al. 
defective attachments suggests that these phosphorylation sites 
are not essential for BubR1  ’  s ability to delay mitotic exit. Indeed, 
the QA or QD mutants did not interfere with the cells  ’   ability to 
become arrested in mitosis for a prolonged period (  >  6 h) in re-
sponse to nocodazole (unpublished data). The reason why the 
phosphomutants were only able to mount a transient delay in 
response to the attachment defects may be because the amount 
of wait anaphase signal generated from these kinetochores is 
not as high as the level generated by unattached kinetochores. 
This is supported by the fact that Mad1 (and thus Mad2) check-
point protein is no longer present at the kinetochores that have 
established microtubule attachments. In the case of nocodazole 
treatment, Mad1 and Mad2 are recruited back to the kineto-
chores, and the full complement of checkpoint proteins is avail-
able to generate a robust level of wait anaphase signal. Similar 
arguments were used to explain why cells depleted of CENP-F 
and hSgo2 only delay transiently despite the presence of numerous 
aberrant attachments (  Feng et al., 2006  ;   H. Huang et al., 2007  ). 
  The behavior of the BubR1 KD mutant was complex. As 
mentioned in the Results, we believe that kinase activity is re-
quired for error correction. However, unlike the phosphomutants 
that exhibited a transient metaphase delay, the KD mutant exited 
mitosis with kinetics similar to wild-type cells. As the anaphase 
cells exhibited a high frequency of lagging chromosomes, the 
KD mutant exited mitosis not because it had repaired its attach-
ment defects but most likely because of its inability to maintain 
the delay. The possibilities are that the KD mutant prevented the 
defective kinetochores from generating a wait anaphase signal 
and that it may also have failed to sustain the checkpoint signal-
ing events that are required to inhibit the APC/C. Others have 
reported that the kinase activity of BubR1 is not essential for 
checkpoint activity (  Tang et al., 2001  ;   Chen, 2002  ;   Harris et al., 
2005  ;   Rancati et al., 2005  ;   Kiyomitsu et al., 2007  ;   Malmanche 
et al., 2007  ). Although this may be true for nocodazole treatment, 
the large number of unattached kinetochores could collectively 
generate suffi  cient amounts of signal to sustain a checkpoint de-
lay. In contrast, subtle kinetochore defects (as seen here) that may 
not generate robust wait anaphase signals may depend more criti-
cally on BubR1 kinase activity. Indeed, our original claim that 
kinase activity was important for the mitotic checkpoint was 
based on the inability of a BubR1 KD mutant to delay cells that 
had only a few unattached kinetochores as a result of treatment 
with a low dose of nocodazole (  Chan et al., 1999  ). The impor-
tance of BubR1 kinase activity in the spindle checkpoint was also 
reported in   Xenopus  , where mutants that lacked kinase activity 
failed to sustain a checkpoint arrest (  Wong and Fang, 2007  ). 
  Analysis of cytosolic extracts prepared from cells released 
from a nocodazole block for different times revealed that only 
S435 was completely dephosphorylated with the same kinetics 
as cyclin B1 degradation. The signifi  cance of the S435 site to 
kinetochore attachments or checkpoint regulation remains to be 
investigated. The phosphorylation of the remaining three sites 
gradually declined as cells exited mitosis. By staining unextracted 
cells, we confi  rmed that phosphorylation of at least S670 was 
detectable in the cytosol of early anaphase cells. The reduced 
level of these phosphorylations in anaphase cells suggests that 
there may be a threshold that maintains the mitotic state. 
kinase activity or the ability of the other sites to be phos-
phorylated by Plk1. However, it remains to be seen whether the 
phosphorylation sites identifi  ed in this study regulate BubR1 
kinase activity. 
  Mechanistically, phosphorylation of BubR1 may be re-
quired for error detection and correction. As long as end-on at-
tachments are not made, BubR1 remains phosphorylated so that 
the error correction system remains active. The kinetochore lo-
calization of MCAK (mitotic centromere  –  associated kinesin), 
aurora B, and hSgo2, proteins thought to partly contribute to the 
error correction system (  Desai et al., 1999  ;   Hauf et al., 2003  ; 
  Andrews et al., 2004  ;   Kline-Smith and Walczak, 2004  ;   Lan et al., 
2004  ;   Cimini et al., 2006  ;   H. Huang et al., 2007  ), were not notice-
ably affected by the phospho-BubR1 mutants (unpublished data). 
As the frequency of attachment defects exhibited by the phospho-
BubR1 mutants seems to be higher than that reported for cells 
depleted of MCAK, other systems may also be affected. More 
recent data that link BubR1 with blinkin, a subunit of the Mis12 
complex (  Kline et al., 2006  ;   Kiyomitsu et al., 2007  ), suggest 
another explanation for the origin of the defective attachments 
seen in the phosho-BubR1 mutants. 
  Our experiments also showed that BubR1 is required by 
kinetochores that have established end-on microtubule attach-
ments to develop tension. This was made evident by the fact that 
both of the S670A and S670D mutants were unable to generate 
normal levels of tension at kinetochores that established end-on 
attachments. Whether phosphorylation of S670 is essential for 
generating tension is diffi  cult to say, as the S670D mutant was 
as equally defective as the S670A mutant. One possibility is that 
the aspartic acid (D) cannot functionally substitute for a phospho-
serine, as in a case where S670 has to undergo cycles of phosphor-
ylation and dephosphorylation. Conceptually, the S670 residue 
may be critical for BubR1 to stimulate downstream kinetochore 
components to generate tension. As the tension defect exhibited 
by the S670 mutants is very similar to that seen when CENP-E 
is depleted from kinetochores (  Yao et al., 2000  ;   McEwen et al., 
2001  ), it is possible that BubR1 regulates CENP-E  ’  s ability to 
generate tension after microtubules have established end-on con-
nections. Although the frequency of lagging chromosomes ex-
hibited by the S670D mutant is low, we cannot exclude the 
possibility that the failure to generate tension might result in chromo-
some nondisjunction, which would not be detected by conven-
tional fl  uorescence microscopy. 
  Our results suggest that BubR1 phosphorylation at S670 
acts in error correction and in promoting tension to end-on at-
tachments. It is noteworthy that immuno-EM data showed that 
BubR1 is localized primarily to the outer kinetochore plate in 
metaphase cells, but in prometaphase cells it was also found to 
occupy a second zone that was situated near the inner plate 
(  Jablonski et al., 1998  ). It is possible that the two functions as-
cribed for phospho-BubR1 refl  ect discrete functional domains 
that are spatially separated within the kinetochore. The loss of 
the inner BubR1 labeling in metaphase cells could also refl  ect 
the reduction of BubR1 that is seen at the light level when micro-
tubules attach. 
  The fact that cells expressing the BubR1 phosphomutants 
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length BubR1 cDNA was cloned into pENTR (Gateway; Invitrogen) to facili-
tate transfer into Destination vectors by in vitro recombination reactions. 
A QuikChange Site-Directed Mutagenesis kit (Agilent Technologies) was 
used to mutate phosphorylation sites as well as to introduce RNAi-resistant 
alleles of BubR1. To make phosphospeciﬁ  c antibodies, phosphopeptides 
were coupled to keyhole limpet hemocyanin and used to immunize rabbits 
(Babco). Serum was passed through a phosphopeptide afﬁ  nity column. The 
eluted antibodies that contain a mixture of phospho- and nonphospho-
antibodies were passed through a nonphosphopeptide column. The ﬂ  ow 
through was tested for phosphospeciﬁ  city. 
  Cell culture and RNAi 
  HeLa cells were grown in DME + 10% FBS in a humidiﬁ  ed incubator at 37  °  C. 
Nocodazole was used at 20-nM (low) and 60-nM (high) ﬁ  nal concentrations. 
  BubR1 siRNA, CAGGAACAACCTCATTCTAAA, was obtained from 
QIAGEN. siRNAs were diluted in serum-free OptiMEM and HiPerfect 
(QIAGEN) as per the manufacturer  ’  s instructions and added to cells so that 
the ﬁ  nal concentration of siRNA was 20 nM. 24  –  36 h after transfection, 
cells were ﬁ  xed and stained or lysed in SDS sample buffer. 
  Cell synchronization and microinjection 
  Cells were synchronized at the G1/S boundary by a double thymidine 
block. Cells were grown in the presence of 2 mM thymidine for 15 h, 
washed, and released into fresh medium for 9 h, and thymidine was added 
for another 15 h. 5  –  6 h after thymidine release, 2  –  4 mg/ml of antibodies 
in PBS was injected into the cytoplasm of cells. Cells were either ﬁ  xed sev-
eral hours later for immunoﬂ  uorescence staining or monitored by time-lapse 
microscopy. To analyze BubR1 mutants in cells depleted of endogenous 
BubR1, siRNAs were transfected at the time of the ﬁ  rst thymidine block. 
DNA was injected as described previously (  Hagting et al., 2002  ;   Di Fiore 
and Pines, 2007  ) into the nucleus of cells the next day, before the second 
round of thymidine was added. Plasmid DNA for injections was diluted in 
PBS into a ﬁ  nal concentration of 50  –  75 ng/  μ  l. Injections were performed 
with a semiautomated microinjector (model 5242; Eppendorf) attached to 
an inverted microscope (Eclipse TE300; Nikon). The cells were plated onto 
no. 1.5 coverslips (18   ×   18 mm), and the injection area was scribed with 
a diamond pen. All cells (    300  –  400) within the scribed loop were 
injected, and viability was   >  95% at 2  –  3 h after injection. 
  Microscopy 
  Cells were ﬁ  xed for 7 min in freshly prepared 3.5% paraformaldehyde/
PBS, pH 6.9, extracted in KB (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, and 
0.1% BSA) with 0.2% Triton X-100 for 5 min at room temperature, and 
rinsed in KB. In some cases, cells were preextracted for 90 s before ﬁ  xing. 
Primary and secondary antibodies were diluted in KB and added to cover-
slips for 30 min at 37  °  C in a humidiﬁ  ed chamber. Commercial antibodies 
to tubulin (Sigma-Aldrich), GST (Cell Signaling Technology), Flag (Sigma-
Aldrich), and Plk1 (Santa Cruz Biotechnology, Inc.) were used. Human anti-
centromere antibody (ACA) serum was provided by J.B. Rattner (University 
of Alberta, Calgary, Canada). Antibodies to human BubR1, CENP-E, and 
Mad1 were obtained from our laboratory (  Liao et al., 1994  ;   Chan et al., 
1998  ;   Jablonski et al., 1998  ;   Campbell et al., 2001  ). Antibodies were 
used at a ﬁ  nal concentration of 0.5  –  1.0   μ  g/ml. Secondary antibodies con-
jugated to Alexa Fluor 488, 555, and 647 (Invitrogen) were used at 1   μ  g/ml. 
Images were visualized with a 100  ×  /1.4 NA objective attached to an 
inverted microscope (Eclipse TE2000S; Nikon), and 0.25  –  1-  μ  m image 
stacks were captured with a charge-coupled device camera (Photometrics 
Cascade 512F; Roper Scientiﬁ  c). Raw images were analyzed with Meta-
Morph software (MDS Analytical Technologies). Images are presented as 
maximum projections and quantitated as previously described (  Hoffman 
et al., 2001  ). Deconvolution was conducted with AutoQuant (Media Cyber-
netics). All image ﬁ  les were reformatted as TIFF ﬁ  les, and Photoshop 
(Adobe) was used to assemble the ﬁ  gures. For time-lapse studies, HeLa or 
HeLa  –  GFP-H2B was plated onto No. 1.5 coverslips (18   ×   18 mm) in Hepes-
buffered medium and imaged with either an Eclipse TE300 or TE2000S in-
verted microscope. Images were captured every 5  –  10 min overnight at 
37  °  C and processed with ImagePro Plus software (Media Cybernetics). 
  Online supplemental material 
  Fig. S1 shows the identiﬁ  cation of BubR1 phosphorylation sites by mass 
spectrometry. Fig. S2 shows the speciﬁ  city of BubR1 phosphoantibodies 
and phosphorylation states of BubR1 in vivo. Fig. S3 shows that phos-
pho-BubR1 mutants do not disrupt Mad1 and CENP-E localization at 
kinetochores. Fig. S4 shows that injected antibodies are concentrated 
at kinetochores, and antibody injections do not affect formation of the 
spindle and localization of Mad1 and CENP-E at kinetochores. Fig. S5 
  We showed that the addition of phospho-BubR1 antibodies 
to checkpoint-arrested extracts delayed the activation of the 
APC/C. These extracts were made from HeLa cells that were 
arrested in mitosis with nocodazole. In the absence of chromo-
somes, APC/C is reactivated after a 30-min lag. During the lag, 
APC/C is inhibited by the checkpoint, as shown recently by as-
sociation of the MCC with the APC/C (  Braunstein et al., 2007  ). 
This was further reinforced in this study, as the addition of 
BubR1 antibodies, the same ones that abrogated the checkpoint 
in cells, accelerated the activation of APC/C. The ability of the 
pS670 antibodies to extend the lag in a dose-dependent manner 
suggests that the phosphorylation state of BubR1 in the extracts 
is a critical determinant of APC/C inhibitory activity. Although 
there are many explanations for how the phosphoantibodies act, 
the most straightforward explanation for which we have evi-
dence is that they preserve the phosphorylation state of BubR1. 
As the majority of BubR1 in the extracts is associated with the 
MCC (  Sudakin et al., 2001  ), we believe that phosphorylation of 
BubR1 is important for MCC inhibitory functions. Indeed, the 
pS670 levels are lowered when APC/C is reactivated. These 
in vitro fi  ndings can be used to explain how the injected pS670 
antibodies and the S670D phosphomutant delayed cells in mitosis. 
In addition to their actions at the kinetochore, the antibodies and 
phosphomimic mutant can prolong the inhibition of the APC/C 
as part of the MCC. 
  The newly identifi  ed phosphorylation sites in BubR1 add 
to the complexity of its regulation. The fact that BubR1 is phos-
phorylated (directly or indirectly) by multiple kinases such as 
Plk1, aurora B, and Mps1 suggests that it is an effector of multi-
ple upstream events. Therefore, BubR1 may integrate and co-
ordinate many of the early events that are required to capture and 
establish end-on microtubule attachments to later events such as 
the generation of tension and silencing of the checkpoint signal-
ing. In addition, phosphorylation of the cytosolic pool of BubR1 
appears to be critically important for regulating mitotic exit. 
  Materials and methods 
  Mass spectrometry 
  BubR1 was immunopuriﬁ   ed from asynchronous and mitotically arrested 
HeLa cells with BubR1 antibodies that were coupled to protein A beads. 
Samples were separated on a precast 4  –  12% denaturing gel (Novex) and 
stained with Colloidal blue (Invitrogen). Bands corresponding to BubR1 
were excised, reduced, alkylated, and digested with trypsin in situ as de-
scribed previously (  Joyal et al., 1997  ). An aliquot of each tryptic digest was 
concentrated on a pipette (C18 ZipTip; Millipore), eluted with 2:1 metha-
nol/ammonium hydroxide (30% vol/vol), and loaded into a nanospray 
needle for analysis by precursor ion-scanning mass spectrometry. Precursor 
ion spectra for m/z 79, a selective marker for phosphopeptides, were re-
corded on a triple quadrupole mass spectrometer (API 3000; Sciex) 
equipped with a nanoelectrospray source and operated in the negative-ion 
mode (  Gomez et al., 2007  ). Phosphopeptides identiﬁ  ed by precursor ion 
scanning were sequenced by liquid chromatography tandem mass spec-
trometry. Peptides were loaded on a trap cartridge and backﬂ  ushed at 
300 nl/min to a 75-  μ  m inner diameter 15-cm column (C18 Zorbax; Agilent 
Technologies) or to a 75-  μ  m inner diameter 15-cm column (PepMap C18; 
Applied Biosystems) using an acetonitrile/water containing 0.1% formic acid 
gradient. The mass spectrometer was set to perform full-time tandem mass 
spectrometry on precursor ions selected for each target phosphopeptide. 
  DNA and antibodies 
  BubR1 was PCR ampliﬁ  ed from a cDNA library (marathon-ready cDNA; 
Clontech Laboratories, Inc.) and conﬁ  rmed by sequence analysis. The full-679 PHOSPHO  -  B  UB  R1 REGULATION OF KINETOCHORE FUNCTIONS   • Huang et al. 
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